Description LOOPERAMIDE * 10 capsules 2mg denomination: loperamide angelini 2 mg rigid capsules
Pharmacotherapeutic category: antidiarrhic; intestinal anti-inflammatories and antimicrobials; Antipropulsive.
Active principles: 1 capsule contains: loperamide mg 2.
Excipients: lactose, starch, talc, magnesium stearate. Capsule bustiness: gelatin, titanium dioxide, E132.
INDICATIONS: Symptomatic treatment of acute diarrhea and re-acquisitions of chronic one.
Contraindications / EFF.Secondar: hypersensitivity to the active ingredient or to any of the excipients. This drug should not be used when any inhibition of the intestinal peristales must be avoided. CONTENTED under the age of 12.
Posology: ATTENTION: Do not use for more than two days. ACUTE.DALTI.ADLI: The initial dose is 2 capsules, then 1 capsule after each subsequent evacuation of non-formed feces (soft). Maximum dose: 8 capsules.diarrea chronic: you can almost always get a normal defecation with a dose adapted to each patient. The initial dose is 2 capsules per day for adults. This initial dose is suitable until obtaining 1 or 2 evacuations of faeces Form yourself a day, which is generally reached with a maintenance dose of 1-6 capsules per day for adults. Not as soon as the normalization of the faeces is obtained, decrease the dose; In the case of stipposes, interrupt the treatment.
Storage: This medicine does not require any particular conservation condition.
Warnings: not to be used under the age of 12. This medicinal product . It is appropriate that patients do not exceed the recommended dose and / or do not protect the duration of therapy.
Interactions: possible interactions can occur with drugs that slow down intestinal peristals (for example the anticholinergic), as the diloperamide effects could be strengthened. You should not recommend the concomitant use of CYP450 cytochrome inhibitors and inhibitors D Glicoprotein P.
UNDENSIDE EFFECTS: if you except some rare case of modest abdominal pain, and dryness of the mouths, there are no undesired effects even after prolonged treatment. Starting suspicious adverse reactions. The signaling of suspected adverse reactions occurring after Authorization of the medicine It is important, as it allows a continuous monitoring of the benefit / risk report of the medicinal product. Healthcare professionals is required to report any suspected adverse reactions through the national reporting system at www.agenziafarmaco.gov.it / content / as-signal-a-suspected-reaction-adverse.
Pregnancy and lactation: in pregnant women, especially in the first quarter, the product must be used only in the event of effective necessities and under the direct doctor’s control.